Advancing Regulatory Science
FDA
discovery that Ad5 vector uses coagulation factor X to block complement
proteins has major implications for gene therapy (PDF - 182KB)
Posted: 5/7/2013
Expanded
and improved approach to identifying surface protein markers could
support development of therapies with human bone marrow multipotent
stromal cells (PDF - 262KB)
Posted: 5/7/2013
Workforce and Patient Safety. April 24, 2024
Hace 5 horas
No hay comentarios:
Publicar un comentario